Screener
ResMed RMD Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The source filing: ResMed’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:19 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000943819-26-000025
| Line item | March 31,2026 | June 30,2025 |
|---|---|---|
| Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued | — | — |
| Common stock, $0.004 par value, 350,000,000 shares authorized; 190,866,303 issued and 145,040,224 outstanding at March 31, 2026 and 190,311,097 issued and 146,385,350 outstanding at June 30, 2025 | 763 | 761 |
| Additional paid-in capital | 2,134,231 | 2,033,599 |
| Retained earnings | 6,958,779 | 6,081,490 |
| Treasury stock, at cost, 45,826,079 shares at March 31, 2026 and 43,925,747 shares at June 30, 2025 | (2,576,957) | (2,073,292) |
| Accumulated other comprehensive loss | (24,905) | (74,699) |
| Total stockholders’ equity | 6,491,911 | 5,967,859 |
| Total liabilities and stockholders’ equity | $8,784,285 | $8,174,391 |
Item 1. Financial Statements
FAQ
- What is ResMed's treasury stock, shares (in shares)?
- ResMed (RMD) reported treasury stock, shares (in shares) of $45.83M in Q1 2026.
- How has ResMed's treasury stock, shares (in shares) changed year-over-year?
- ResMed's treasury stock, shares (in shares) increased by 5.3% year-over-year, from $43.51M to $45.83M.
- What is the long-term trend for ResMed's treasury stock, shares (in shares)?
- Over 3 years (2022 to 2025), ResMed's treasury stock, shares (in shares) has grown at a 1.6% compound annual growth rate (CAGR), from $41.84M to $43.93M.
Ask your AI about ResMed's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude